Articles related to CANCER SCREENING

Breast cancer screening remains a persistent area of variation in clinical practice. Updated guidance from the American College of Physicians aims to clarify when screening offers meaningful benefit for average‑risk patients — and when it may not.

Supplemental MRI for women with extremely dense breasts and higher-than-average risk “could be cost-effective if MRI costs and false-positive biopsy rates are reduced.” — Tosteson et al., Annals of Internal Medicine

“A lot of our individuals are young, so we’ve seen this cancer being diagnosed during or after pregnancy, and often it gets labeled as hemorrhoids … but in hindsight, probably should have warranted attention earlier.” – Pashtoon Kasi, MD

“I’d always associated cancer with age and with unhealthy, sedentary lifestyles. But I was in amazing cardiovascular shape.” — James Van Der Beek, People magazine

The Aptima HPV assay uses messenger RNA detection to identify infections most likely to lead to cervical cancer.

Despite the scale of prostate-specific antigen (PSA) testing for prostate cancer screening, prediction models do not predict time-to-event end points or adjust for patient life expectancy.